	Ebit		Date
AbbVie	USD 5.81B	4.36B	2025-12
Alaunos Therapeutics	USD -1.19M	148K	2025-09
Amgen	USD 3.96B	464M	2025-12
Ardelyx	USD 7.12M	19.62M	2025-09
Arrowhead Research	USD 40.81M	17.01M	2025-12
Bayer	EUR -399M	363M	2025-09
Biogen	USD 659.6M	157M	2025-09
Corcept Therapeutics	USD 4.49M	5.73M	2025-12
Curis	USD -12.37M	230K	2023-09
Gilead Sciences	USD 2.96B	551M	2025-12
Infinity Pharmaceuticals	USD -10.12M	1.39M	2023-06
J&J	USD 5.11B	2.3B	2025-12
Karyopharm Therapeutics	USD -26.28M	1.84M	2024-09
Novartis	USD -9.19B	13.87B	2025-06
Novavax	USD -134.02M	49.55M	2024-09
PTC Therapeutics	USD -81.62M	85.11M	2025-12
Puma Biotechnology	USD -2.2M	11.41M	2024-06
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Roche Holding	CHF 9.56B	2.1B	2025-12
TG Therapeutics	USD 50.49M	21.13M	2025-12
Verastem	USD -37.03M	6M	2024-09
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12

TG Therapeutics - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.